Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Appointed director
|
|
Phio Pharmaceuticals Corp. (RXII)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Bitterman Robert J (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Paid exercise price by delivering 917 shares
@ $1.51, valued at
$1.4k
|
|
| 07/05/2023 |
4
| Bitterman Robert J (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Bought 1,000 shares
@ $2.88, valued at
$2.9k
Bought 1,000 shares
@ $2.84, valued at
$2.8k
|
|
| 06/15/2023 |
4
| Ferrara Robert L (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Bought 2,000 shares
@ $3.1, valued at
$6.2k
|
|
| 02/22/2023 |
4
| Lockshin Curtis (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 1,500 shares
@ $0 |
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| CAUWENBERGH GEERT (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 1,500 shares
@ $0 |
|
| 02/22/2023 |
4
| BRADFORD PATRICIA A (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 1,500 shares
@ $0 |
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2023 |
4
| Bitterman Robert J (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 11,000 shares
@ $0 |
|
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Bitterman Robert J (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 09/26/2022 |
4
| BRADFORD PATRICIA A (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 03/03/2022 |
4
| Kontulis Caitlin (Secretary & VP Finance & Admin) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Paid exercise price by delivering 4,011 shares
@ $0.821, valued at
$3.3k
|
|
| 03/03/2022 |
4
| Dispersyn Gerrit (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Paid exercise price by delivering 8,954 shares
@ $0.821, valued at
$7.4k
|
|
| 02/16/2022 |
4
| Lockshin Curtis (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/16/2022 |
4
| Kontulis Caitlin (Secretary & VP Finance & Admin) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 68,000 shares
@ $0 |
|
| 02/16/2022 |
4
| Freeman Jonathan E (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/16/2022 |
4
| Ferrara Robert L (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/16/2022 |
4
| Dorman H. Paul (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/16/2022 |
4
| Dispersyn Gerrit (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 126,000 shares
@ $0 |
|
| 02/16/2022 |
4
| CAUWENBERGH GEERT (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/16/2022 |
4
| Bitterman Robert J (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 08/17/2021 |
4
| Dispersyn Gerrit (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Bought 6,000 shares
@ $1.63, valued at
$9.8k
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|